These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35504624)

  • 1. Covid-19: Campaign takes on Pfizer's "profiteering".
    Shepherd A
    BMJ; 2022 May; 377():o1111. PubMed ID: 35504624
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving end-to-end success in the clinic: Pfizer's learnings on R&D productivity.
    Fernando K; Menon S; Jansen K; Naik P; Nucci G; Roberts J; Wu SS; Dolsten M
    Drug Discov Today; 2022 Mar; 27(3):697-704. PubMed ID: 34922020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pfizer's small-molecule antiviral misses on COVID prevention.
    Mullard A
    Nat Rev Drug Discov; 2022 Jun; 21(6):406. PubMed ID: 35538236
    [No Abstract]   [Full Text] [Related]  

  • 4. Pfizer's puzzle.
    Simons J
    Fortune; 2006 Apr; 153(7):152-4, 156. PubMed ID: 16649633
    [No Abstract]   [Full Text] [Related]  

  • 5. Stockholders protest Pfizer's drug prices.
    Lenzer J
    CMAJ; 2004 Jul; 171(1):24. PubMed ID: 15238486
    [No Abstract]   [Full Text] [Related]  

  • 6. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals. Pfizer's shakeup means less money for research.
    Kean S
    Science; 2011 Feb; 331(6018):658. PubMed ID: 21310976
    [No Abstract]   [Full Text] [Related]  

  • 8. Profiteering from vaccine inequity: a crime against humanity?
    Hassan F; Yamey G; Abbasi K
    BMJ; 2021 Aug; 374():n2027. PubMed ID: 34400410
    [No Abstract]   [Full Text] [Related]  

  • 9. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 10. Learning lessons from Pfizer's $800 million failure.
    Nat Rev Drug Discov; 2011 Mar; 10(3):163-4. PubMed ID: 21358723
    [No Abstract]   [Full Text] [Related]  

  • 11. What does Pfizer's merger mean for drug development?
    Mullard A
    Lancet; 2016 Jan; 387(10013):14-5. PubMed ID: 26766335
    [No Abstract]   [Full Text] [Related]  

  • 12. Pfizer's DRUMBEAT program.
    Chapman KG
    J Parenter Drug Assoc; 1980; 34(3):217-23. PubMed ID: 6901776
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer Drugs Remain Hot Targets.
    Cancer Discov; 2016 Nov; 6(11):OF3. PubMed ID: 27694379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole: Pfizer asked to lower Africa price.
    James JS
    AIDS Treat News; 2000 Mar; (339):5-6. PubMed ID: 12870451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
    Dahl E; Lindstrand G
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):665. PubMed ID: 15804040
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA draft guidance on adaptive design clinical trials: Pfizer's perspective.
    Chuang-Stein C; Beltangady M
    J Biopharm Stat; 2010 Nov; 20(6):1143-9. PubMed ID: 21058110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pfizer's open data policy should include trials of off-label uses, say critics.
    Kmietowicz Z
    BMJ; 2013 Dec; 347():f7327. PubMed ID: 24319259
    [No Abstract]   [Full Text] [Related]  

  • 18. US court invalidates Pfizer’s Celebrex® patent.
    Pharm Pat Anal; 2014 May; 3(3):224. PubMed ID: 25129896
    [No Abstract]   [Full Text] [Related]  

  • 19. India’s IP appellate board upholds Pfizer’s detrol® patent.
    Pharm Pat Anal; 2014 May; 3(3):223. PubMed ID: 24998285
    [No Abstract]   [Full Text] [Related]  

  • 20. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.